Generate Biomedicines raises $700.0M Series C (United States, Jun 2026)
Reach the investors backing rounds like this
Backed by Nvidia, Amgen · verified emails and LinkedIn on Datapile
Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery - Crypto Briefing
Generate Biomedicines is a biotech startup focused on AI-driven drug discovery, specifically in the generation and optimization of therapeutic proteins. The company aims to significantly reduce the time required for drug discovery, with a pipeline that includes a Phase 3 clinical trial for severe asthma and multiple oncology candidates with FDA Fast Track designation.
Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery Crypto Briefing
20,207 investors back startups in United States
You just read who funded Generate Biomedicines. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.